rebranding
FogPharma Rebrands to Parabilis Medicines, Emphasizing AI-Driven Drug Discovery
FogPharma, Parabilis Medicines, AI capabilities, drug discovery, rebranding
Aeterna Zentaris Rebrands as COSCIENS Biopharma: A New Era in Biopharmaceuticals
Aeterna Zentaris, COSCIENS Biopharma, biopharmaceuticals, rebranding, name change, therapeutic development, diagnostic tests, Macrilen, adult growth hormone deficiency